Redmile Group, LLC - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 45 filers reported holding LOGICBIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$8,097,000
-23.6%
749,026
-8.1%
0.27%
-9.7%
Q2 2019$10,594,000
+17.9%
814,898
-10.4%
0.30%
+14.1%
Q1 2019$8,989,000
-5.1%
909,787
-0.2%
0.26%
-31.0%
Q4 2018$9,477,000911,2870.38%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Lion Point Capital, LP 500,000$2,470,0000.65%
Orbimed Advisors 6,466,783$31,946,0000.54%
SAMLYN CAPITAL, LLC 798,566$3,945,0000.10%
ADAGE CAPITAL PARTNERS GP, L.L.C. 915,355$4,522,0000.01%
IHT Wealth Management, LLC 11,660$58,0000.01%
FIDUCIARY TRUST CO 37,998$188,0000.01%
FRANKLIN RESOURCES INC 700,000$3,458,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 13,700$68,0000.00%
Tower Research Capital LLC (TRC) 2,249$11,0000.00%
MANCHESTER FINANCIAL INC 200$1,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders